RYR1 and Alzheimer disease: Although the relationship between ΔoxCCO concentration and AD pathology might not be linear, studies have shown that amyloid-β protein precursors reportedly block mitochondrial CCO, and consequently this inhibition could instigate the shift toward the amyloidogenic pathway.16